Header Logo

Connection

GAGAN SOOD to Humans

Back to Details
This is a "connection" page, showing publications GAGAN SOOD has written about Humans.
GAGAN SOOD
Connection Strength
0.143
Humans
  1. Pathogenesis of Alcoholic Liver Disease: An Update. Clin Liver Dis. 2019 02; 23(1):71-80.
    View in: PubMed
    Score: 0.017
  2. Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: A systematic review and meta-analysis. Clin Transplant. 2017 02; 31(2).
    View in: PubMed
    Score: 0.015
  3. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014 Apr 21; 20(15):4115-27.
    View in: PubMed
    Score: 0.012
  4. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review. J Viral Hepat. 2013 Sep; 20(9):593-9.
    View in: PubMed
    Score: 0.012
  5. Extended treatment duration for treatment na?ve chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin. J Viral Hepat. 2011 Apr; 18(4):e99-103.
    View in: PubMed
    Score: 0.010
  6. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010 May; 25(5):880-5.
    View in: PubMed
    Score: 0.009
  7. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17(1):1-15.
    View in: PubMed
    Score: 0.009
  8. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):192-9.
    View in: PubMed
    Score: 0.009
  9. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol. 2008 Dec; 23(12):1942.
    View in: PubMed
    Score: 0.008
  10. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1396-402.
    View in: PubMed
    Score: 0.008
  11. Neutropenic enterocolitis: An unusual complication of HCV combination therapy with PEG-IFN and ribavirin. Eur J Intern Med. 2008 Jul; 19(5):372-3.
    View in: PubMed
    Score: 0.008
  12. Sleeping Beauty and Hepatitis B: An Evidence-Based Guide for Dermatologists. Skinmed. 2021; 19(1):37-41.
    View in: PubMed
    Score: 0.005
  13. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393.
    View in: PubMed
    Score: 0.005
  14. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.004
  15. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.004
  16. Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma. Ann Intern Med. 2017 Sep 05; 167(5):361-362.
    View in: PubMed
    Score: 0.004
  17. Small bowel adenocarcinoma mimicking tubercular stricture. Role of enteroscopy in early diagnosis. J Assoc Physicians India. 1991 Mar; 39(3):284-5.
    View in: PubMed
    Score: 0.002
  18. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity! Semin Liver Dis. 2002 Nov; 22(4):395-406.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.